|
|
|
Insider
Information: |
Fuchs Henry J |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
222,228 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,063,061 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
222,228 |
|
|
Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-16 |
4 |
AS |
$32.04 |
$33,386 |
D/D |
(1,042) |
17,292 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-30 |
4 |
S |
$38.19 |
$956,260 |
D/D |
(25,000) |
17,292 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
18,016 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-05-17 |
4 |
AS |
$31.84 |
$33,145 |
D/D |
(1,041) |
18,334 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-10 |
4 |
S |
$32.00 |
$320,011 |
D/D |
(10,000) |
18,334 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-13 |
4 |
S |
$32.00 |
$480,478 |
D/D |
(15,000) |
18,334 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
19,375 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
|
2009-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-04-01 |
4 |
S |
$24.00 |
$139,974 |
D/D |
(5,833) |
20,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-05-03 |
4 |
S |
$22.79 |
$51,870 |
D/D |
(2,275) |
20,000 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2012-04-25 |
4 |
OE |
$2.76 |
$27,600 |
D/D |
10,000 |
20,416 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-04-30 |
4 |
A |
$13.23 |
$19,072 |
D/D |
1,442 |
21,442 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-09-15 |
4 |
OE |
$21.01 |
$131,313 |
D/D |
6,250 |
22,183 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-05-03 |
4 |
OE |
$11.05 |
$9,205 |
D/D |
833 |
22,275 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2011-04-20 |
4 |
S |
$27.00 |
$355,455 |
D/D |
(13,165) |
22,835 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-06-23 |
4 |
OE |
$21.01 |
$131,313 |
D/D |
6,250 |
23,225 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2011-04-29 |
4 |
A |
$13.23 |
$21,426 |
D/D |
1,620 |
24,455 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-04-01 |
4 |
OE |
$11.05 |
$64,455 |
D/D |
5,833 |
25,833 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-10 |
4 |
OE |
$21.01 |
$210,100 |
D/D |
10,000 |
28,334 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-04-20 |
4 |
AS |
$35.00 |
$269,185 |
D/D |
(7,691) |
28,920 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-04-30 |
4 |
A |
$19.35 |
$21,242 |
D/D |
1,098 |
30,018 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-05-01 |
4 |
AS |
$34.99 |
$174,950 |
D/D |
(5,000) |
30,018 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
31,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-06-02 |
4 |
AS |
$20.00 |
$16,680 |
D/D |
(834) |
31,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2010-07-23 |
4 |
AS |
$20.00 |
$16,660 |
D/D |
(833) |
31,000 |
0 |
- |
|
294 Records found
|
|
Page 4 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|